
Eudragit encapsulated cationic poly (lactic-co-glycolic acid) nanoparticles in targeted delivery of capecitabine for augmented colon carcinoma therapy
Keywords: Cancer; Colon carcinoma; Capecitabine; Drug delivery; Poly(lactic-co-glycolic acid); Eudragit® S100; Full factorial design; Nanoparticles;